Cargando…

Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol

Introduction: Evidence syntheses, often in the form of systematic reviews, are essential for clinical guideline development and informing changes to health policies. However, clinical guideline development groups (CGDG) are multidisciplinary, and participants such as policymakers, healthcare profess...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharp, Melissa K., Tyner, Barrie, Awang Baki, Dayang Anis Binti, Farrell, Cormac, Devane, Declan, Mahtani, Kamal R., Smith, Susan M., O'Neill, Michelle, Ryan, Máirín, Clyne, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433911/
https://www.ncbi.nlm.nih.gov/pubmed/36071877
http://dx.doi.org/10.12688/hrbopenres.13325.2
_version_ 1784780739278012416
author Sharp, Melissa K.
Tyner, Barrie
Awang Baki, Dayang Anis Binti
Farrell, Cormac
Devane, Declan
Mahtani, Kamal R.
Smith, Susan M.
O'Neill, Michelle
Ryan, Máirín
Clyne, Barbara
author_facet Sharp, Melissa K.
Tyner, Barrie
Awang Baki, Dayang Anis Binti
Farrell, Cormac
Devane, Declan
Mahtani, Kamal R.
Smith, Susan M.
O'Neill, Michelle
Ryan, Máirín
Clyne, Barbara
author_sort Sharp, Melissa K.
collection PubMed
description Introduction: Evidence syntheses, often in the form of systematic reviews, are essential for clinical guideline development and informing changes to health policies. However, clinical guideline development groups (CGDG) are multidisciplinary, and participants such as policymakers, healthcare professionals and patient representatives can face obstacles when trying to understand and use evidence synthesis findings. Summary formats to communicate the results of evidence syntheses have become increasingly common, but it is currently unclear which format is most effective for different stakeholders. This mixed-methods systematic review (MMSR) evaluates the effectiveness and acceptability of different evidence synthesis summary formats for CGDG members. Methods: This protocol follows guidance from the Joanna Briggs Institute on MMSRs and is reported according to the Preferred Reporting Items for Systematic Reviews (PRISMA)-P guideline. A comprehensive search of six databases will be performed with no language restrictions. Primary outcomes are those relating to the effectiveness and preferences for and attitudes towards the different summary formats. We will include qualitative research and randomised controlled trials. Two reviewers will perform title, abstract, and full-text screening. Independent double-extraction of study characteristics and critical appraisal items will be undertaken using a standardised form. We will use a convergent segregated approach to analyse quantitative and qualitative data separately; results will then be integrated. Discussion: The results of this systematic review will provide an overview of the effectiveness and acceptability of different summary formats for evidence synthesis findings. These findings can be helpful for those in or communicating to guideline development groups. The results can also inform the development and pilot-testing of summary formats for evidence summaries.
format Online
Article
Text
id pubmed-9433911
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-94339112022-09-06 Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol Sharp, Melissa K. Tyner, Barrie Awang Baki, Dayang Anis Binti Farrell, Cormac Devane, Declan Mahtani, Kamal R. Smith, Susan M. O'Neill, Michelle Ryan, Máirín Clyne, Barbara HRB Open Res Study Protocol Introduction: Evidence syntheses, often in the form of systematic reviews, are essential for clinical guideline development and informing changes to health policies. However, clinical guideline development groups (CGDG) are multidisciplinary, and participants such as policymakers, healthcare professionals and patient representatives can face obstacles when trying to understand and use evidence synthesis findings. Summary formats to communicate the results of evidence syntheses have become increasingly common, but it is currently unclear which format is most effective for different stakeholders. This mixed-methods systematic review (MMSR) evaluates the effectiveness and acceptability of different evidence synthesis summary formats for CGDG members. Methods: This protocol follows guidance from the Joanna Briggs Institute on MMSRs and is reported according to the Preferred Reporting Items for Systematic Reviews (PRISMA)-P guideline. A comprehensive search of six databases will be performed with no language restrictions. Primary outcomes are those relating to the effectiveness and preferences for and attitudes towards the different summary formats. We will include qualitative research and randomised controlled trials. Two reviewers will perform title, abstract, and full-text screening. Independent double-extraction of study characteristics and critical appraisal items will be undertaken using a standardised form. We will use a convergent segregated approach to analyse quantitative and qualitative data separately; results will then be integrated. Discussion: The results of this systematic review will provide an overview of the effectiveness and acceptability of different summary formats for evidence synthesis findings. These findings can be helpful for those in or communicating to guideline development groups. The results can also inform the development and pilot-testing of summary formats for evidence summaries. F1000 Research Limited 2022-05-10 /pmc/articles/PMC9433911/ /pubmed/36071877 http://dx.doi.org/10.12688/hrbopenres.13325.2 Text en Copyright: © 2022 Sharp MK et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Sharp, Melissa K.
Tyner, Barrie
Awang Baki, Dayang Anis Binti
Farrell, Cormac
Devane, Declan
Mahtani, Kamal R.
Smith, Susan M.
O'Neill, Michelle
Ryan, Máirín
Clyne, Barbara
Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol
title Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol
title_full Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol
title_fullStr Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol
title_full_unstemmed Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol
title_short Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol
title_sort evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433911/
https://www.ncbi.nlm.nih.gov/pubmed/36071877
http://dx.doi.org/10.12688/hrbopenres.13325.2
work_keys_str_mv AT sharpmelissak evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol
AT tynerbarrie evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol
AT awangbakidayanganisbinti evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol
AT farrellcormac evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol
AT devanedeclan evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol
AT mahtanikamalr evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol
AT smithsusanm evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol
AT oneillmichelle evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol
AT ryanmairin evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol
AT clynebarbara evidencesynthesissummaryformatsforclinicalguidelinedevelopmentgroupmembersamixedmethodssystematicreviewprotocol